Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
6.67
+0.17 (2.54%)
At close: Jun 26, 2026, 4:00 PM EDT
6.50
-0.17 (-2.48%)
After-hours: Jun 26, 2026, 4:00 PM EDT
Alpha Cognition Revenue
Alpha Cognition had revenue of $3.53M in the quarter ending March 31, 2026, with 20.66% growth. This brings the company's revenue in the last twelve months to $10.83M, up 269.64% year-over-year. In the year 2025, Alpha Cognition had annual revenue of $10.22M.
Revenue (ttm)
$10.83M
Revenue Growth
+269.64%
P/S Ratio
12.47
Revenue / Employee
$152,471
Employees
71
Market Cap
145.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.22M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADC Therapeutics | 79.18M |
| Pyxis Oncology | 13.86M |
| Humacyte | 2.02M |
| Molecular Partners AG | 856.30K |
| Spruce Biosciences | 697.00K |
| Connect Biopharma Holdings | 233.00K |
ACOG News
- 3 days ago - Alpha Cognition appoints Robert Wills as chairman of the board - TheFly
- 3 days ago - Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board - Business Wire
- 10 days ago - Alpha Cognition announces enrollment of first patient in Resolve - TheFly
- 10 days ago - Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer's Disease - Business Wire
- 17 days ago - Alpha Cognition reports results from Beacon real-world study of Zunevyl - TheFly
- 17 days ago - Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer's Disease - Business Wire
- 4 weeks ago - Maxim starts Alpha Cognition at Buy, sees ‘significant’ market opportunity - TheFly
- 4 weeks ago - Alpha Cognition initiated with a Buy at Maxim - TheFly